Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men

Autor: Julien Paccou, N. Viget, Elodie Drumez, Bernard Cortet, Olivier Robineau
Rok vydání: 2018
Předmět:
Zdroj: Médecine et Maladies Infectieuses. 48:442-448
ISSN: 0399-077X
DOI: 10.1016/j.medmal.2018.02.009
Popis: Objective We aimed to investigate the prevalence of low bone mineral density (BMD) and associated factors in antiretroviral therapy (ART)-naive HIV-infected young men. Methods In this cross-sectional study, dual-energy X-ray absorptiometry (DXA) was used to measure BMD. BMD at the lumbar spine, total hip and femoral neck sites was expressed as a Z-score (number of standard deviations away from the mean in an age, race and sex-matched reference population). Low BMD was defined as Z-scores ≤ −2 at any of the three sites. The prevalence of low BMD was evaluated at the lumbar spine, total hip and femoral neck sites, as were risk factors associated with Z-scores. Results The study cohort comprised 49 men, of whom 87.8% were white. Mean age was 31.6 (± 7.7) years and mean BMI was 22.7 (± 4.0) kg/m2. Half of patients (51.0%) were current smokers. The prevalence of low BMD was 24.5% [95% CI, 13.3–38.9]. Low estradiol levels and low BMI were associated with low Z-scores at each skeletal site, whereas current smoking and high IGF1 levels were associated with low Z-scores at the lumbar spine site. Among the HIV-related factors, low CD4+ cell count was associated with low Z-scores at the lumbar spine site. Conclusions We observed a high prevalence of low BMD in our ART-naive cohort of young men. Risk factors associated with low Z-scores were those usually observed in HIV-infected individuals (low BMI, current smoking and CD4+ cell count) or linked to endocrine hormone levels (estradiol, IGF-1).
Databáze: OpenAIRE